20(S)‐protopanaxatriol inhibited D‐galactose‐induced brain aging in mice via promoting mitochondrial autophagy flow
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7779 ↗At a glance
Journal article in Phytotherapy Research, 2023. Written by Jun-Jie Zhang and 10 co-authors. Institution: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. Major MEDLINE topics: Ginsenosides, Panax. Cited 19 times so far (Crossref); 45 references. Funded by: Jilin Science & Technology Development Plan, National Natural Science Foundation of China.
Abstract (original language)
Previous reports have confirmed that saponins (ginsenosides) derived from Panax ginseng . C. A. Meyer exerted obvious memory‐enhancing and antiaging effects, and the simpler the structure of ginsenosides, the better the biological activity. In this work, we aimed to explore the therapeutic effect and underlying molecular mechanism of 20(S)‐protopanaxatriol (PPT), the aglycone of panaxatriol‐type ginsenosides, by establishing D‐galactose (D‐gal)‐induced subacute brain aging model in mice. The results showed that PPT treatment (10 and 20 mg/kg) for 4 weeks could significantly restore the D‐gal (800 mg/kg for 8 weeks)‐induced impaired memory function, choline dysfunction, and redox system imbalance in mice. Meanwhile, PPT also significantly reduced the histopathological changes caused by D‐gal exposure. Moreover, PPT could increase TFEB/LAMP2 protein expression to promote mitochondrial autophagic flow. Importantly, the results from molecular docking showed that PPT had good binding ability with LAMP2 and TFEB, suggesting that TFEB/LAMP2 might play an important role in PPT to alleviate D‐gal‐caused brain aging.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
- National & Local Joint Engineering Research Center for Ginseng Breeding and Development, Changchun, 130118, China.
- Looking Up Starry Sky Medical Research Center, Siping, 136001, China.
- Goldenwell Biotechnology, Inc., Reno, Nevada, 89501, USA.
ORCID profiles: Wei Li
Funding
- Jilin Science & Technology Development Plan
- National Natural Science Foundation of China
Cite
APA
Zhang, J. J., Hu, R. Y., Chen, K. C., Liu, Y. B., Hou, Y. Y., Zhang, Y. Z., Feng, Z. M., Chen, R. X., Zheng, Y. N., Liu, S., & Li, W. (2023). 20(S)‐protopanaxatriol inhibited D‐galactose‐induced brain aging in mice via promoting mitochondrial autophagy flow. Phytotherapy Research. https://doi.org/10.1002/ptr.7779
Vancouver
Zhang JJ, Hu RY, Chen KC, Liu YB, Hou YY, Zhang YZ, et al. 20(S)‐protopanaxatriol inhibited D‐galactose‐induced brain aging in mice via promoting mitochondrial autophagy flow. Phytotherapy Research. 2023. doi:10.1002/ptr.7779
BibTeX
@article{Zhang2023,
author = {Zhang, Jun-Jie and Hu, Rui-Yi and Chen, Ke-Cheng and Liu, Yong-Bo and Hou, Yun-Yi and Zhang, Yu-Zhuo and Feng, Zi-Meng and Chen, Ri-Xin and Zheng, Yi-Nan and Liu, Shuang and Li, Wei},
title = {20(S)‐protopanaxatriol inhibited D‐galactose‐induced brain aging in mice via promoting mitochondrial autophagy flow},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7779}
}
EUVIMED